Juan F. Cueva - Publications

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panel.

Journal: Molecular oncology

Published: October 25, 2025

An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 10, 2025

Red blood cell-tumor cell interactions promote tumor cell progression.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 17, 2024

Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patients.

Journal: Journal of translational medicine

Published: October 24, 2024

Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 08, 2024

Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01).

Journal: Gynecologic oncology

Published: September 18, 2024

Nutritional ketosis modulates the methylation of cancer-related genes in patients with obesity and in breast cancer cells.

Journal: Journal of physiology and biochemistry

Published: July 09, 2024

Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 09, 2024

Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients".

Journal: Molecular & cellular proteomics : MCP

Published: May 12, 2024

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.

Journal: EClinicalMedicine

Published: October 19, 2023

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 31, 2022

Noninvasive detection of microsatellite instability in patients with endometrial cancer.

Journal: International journal of cancer

Published: October 21, 2022